LIVZON PHARMAC. GRP H YC1 revenue breakdown overview

LIVZON PHARMAC. GRP H YC1 revenue for the last year amounted to 1.56 B EUR, the most of which — 824.70 M EUR — came from its highest performing source at the moment, Chemical Drug Preparations, the year earlier bringing 842.20 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought LIVZON PHARMAC. GRP H YC1 1.34 B EUR, and the year before that — 1.38 B EUR.